Popular Articles

Immune Cell Function Can Be Suppressed By Leading Pathogen In Newborns
Group B Streptococcus (GBS), a bacterial pathogen that causes sepsis and meningitis in newborn infants, is able to shut down immune cell function in order to promote its own survival, according to researchers at the University of California, San Diego School of Medicine and the Skaggs School of Pharmacy and Pharmaceutical Sciences. Their study, published online July 13 in the Journal of Experimental Medicine, offers insight into GBS infection - information that may lead to new medical therapies for invasive infectious diseases that affect nearly 3,500 newborns in the United States each year.

UC Davis Researchers Develop New Test For Fragile X Syndrome
Researchers at UC Davis have developed a new test that will measure the protein deficit responsible for fragile X syndrome - the single-most common cause of intellectual impairment and the most-commonly inherited cause of autism. The test, described in a study appearing online in the July 2009 issue of The Journal of Molecular Diagnostics, is the first to measure an individual"s level of the fragile X mental retardation 1 (FMR1) protein.
News of the day
Childhood Asthma Worsened By Stress And Depression, UB Researchers Show
Young people with asthma have nearly twice the incidence of depression compared to their peers without asthma, and studies have shown that depression is associated with increased asthma symptoms and, in some cases, death.
Cardiovascular

Retroperitoneal Lymph Node Dissection In Patients With High Risk Testicular Cancer

UroToday.com - We performed a retrospective review of retroperitoneal lymph node dissection (RPLND) patients with high risk features (>30% embryonal carcinoma, with or without lymphovascular invasion) and compared primary (P-RPLND) versus post-chemotherapy (PC-RPLND) patients. The average percent embryonal carcinoma between P-RPLND vs. PC-RPLND was 75.3 vs. 71.2%, respectively. The average LVI between P-RPLND vs. PC-RPLND was 53.4 vs. 61.4%, respectively. Regarding pathologic stage II (PS II) disease, there were 37 (49%) and 35 (61%) cases, respectively. Only 2 (3%) of patients who underwent P-RPLND were noted to have systemic disease outside the retroperitoneum (metastasis to the lung and mesentery each). Overall, there were 6 (8%) and 5 (9%) recurrences between the P-RPLND and PC-RPLND groups all within 2 years of surgery. P-RPLND offered less blood loss, shorter operative time and fewer complications than PC-RPLND. Our findings highlight that P-RPLND can spare a majority of these high risk patients the potential long-term toxicity of chemotherapy compounded by radiation exposure from surveillance imaging. Written by Stephen Williams, MD as part of Beyond the Abstract on UroToday.com UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice. To access the latest urology news releases from UroToday, go to: www.urotoday.com Copyright © 2009 - UroToday


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):